Javascript must be enabled to continue!
Overview of Platelet Levels of Patients with Pulmonary Tuberculosis at Kabila Health Center
View through CrossRef
The purpose of this study was to determine the results of the examination of normal and abnormal levels of platelets in patients with pulmonary tuberculosis and the causative factors that influence these levels.
This research method used a descriptive quantitative approach method. The population in this study were all patients with pulmonary tuberculosis at the Kabila Health Center as many as 23 patients. The sample used was 23 respondents using the Total Sampling technique.
The results showed that the abnormal platelet levels were 14.6% and normal platelet levels were 82.6%. Patients aged 15-50 years have abnormal platelet levels (17.4%) and normal platelet levels (82.6%). Patients with an age range of >50 years had normal platelet levels (21.7%). Male patients had normal platelet levels (26.1%), while women had abnormal platelet levels (17.4%) and had normal platelet levels (56.5%). Patients weighing 30-35kg 8.7% had abnormal platelet levels, and 4.34% had normal platelet levels. At 36-45 kg of body weight, 8.7% had abnormal platelet levels and 65.2% had normal platelet levels. At 46-55 kg of body weight, 8.7% had normal platelet levels and at 56-65 kg, 4.3% had normal platelet levels. Another factor is the length of treatment. In patients with two months of treatment, 8.7% had normal platelet levels, 17.3% had abnormal platelet levels, and 74% had normal platelet levels
Universitas Bina Mandiri Gorontalo
Title: Overview of Platelet Levels of Patients with Pulmonary Tuberculosis at Kabila Health Center
Description:
The purpose of this study was to determine the results of the examination of normal and abnormal levels of platelets in patients with pulmonary tuberculosis and the causative factors that influence these levels.
This research method used a descriptive quantitative approach method.
The population in this study were all patients with pulmonary tuberculosis at the Kabila Health Center as many as 23 patients.
The sample used was 23 respondents using the Total Sampling technique.
The results showed that the abnormal platelet levels were 14.
6% and normal platelet levels were 82.
6%.
Patients aged 15-50 years have abnormal platelet levels (17.
4%) and normal platelet levels (82.
6%).
Patients with an age range of >50 years had normal platelet levels (21.
7%).
Male patients had normal platelet levels (26.
1%), while women had abnormal platelet levels (17.
4%) and had normal platelet levels (56.
5%).
Patients weighing 30-35kg 8.
7% had abnormal platelet levels, and 4.
34% had normal platelet levels.
At 36-45 kg of body weight, 8.
7% had abnormal platelet levels and 65.
2% had normal platelet levels.
At 46-55 kg of body weight, 8.
7% had normal platelet levels and at 56-65 kg, 4.
3% had normal platelet levels.
Another factor is the length of treatment.
In patients with two months of treatment, 8.
7% had normal platelet levels, 17.
3% had abnormal platelet levels, and 74% had normal platelet levels.
Related Results
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
PATHOPHYSIOLOGY OF THROMBOCYTOPENIA AND RESULTANT CLINICAL INDICATIONS FOR PLATELET TRANSFUSION
Careful evaluation of platelet survival data in normal individuals and patients with thrombocytopeniasecondary to marrow aplasia has demonstrated that platelets are lost from circu...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Abstract
Background :Tuberculosis (TB) is a major public health concern worldwide and is the 13th leading cause of death and the second deadliest infectious disease after C...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposition following an enviro...
Autoimmune thrombocytopenic purpura
Autoimmune thrombocytopenic purpura
Abstract
Adult autoimmune throbocytopenic purpura (ATP) is a platelet disorder that develops in certain individuals with a genetic as well as sex (female) predisposi...

